Bionpharma Inc. recalls

All Bionpharma Inc. recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (3).

3 recalls published between October 23, 2024 and September 9, 2026. Most common issues: sterility (1), microbial contamination (1). 1 was FDA Class I, the most serious level.

• Doxylamine Succinate and Pyridoxine HCl Delayed-Release tablets 10 mg/10… recall
  FDA September 9, 2026 · Bionpharma Inc. · Class III
• Divalproex Sodium Delayed-Release Tablets, USP, 500 mg… recall
  FDA July 29, 2026 · Bionpharma Inc. · Class II
• Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only… recall
  FDA October 23, 2024 · Bionpharma Inc. · Class I